Biomarker of Diabetic Retinopathy

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

Diabetic retinopathy (DR) is a complication of diabetes in which blood vessels supplying blood to the back of the eye (retina) are dysfunctional. This can lead to an improper supply of oxygen and nutrients to the retinal tissue, or it may trigger the formation of new blood vessels in response to the oxygen/nutrient deficiency. Ultimately affecting the normal vision. There is no known marker that will provide information on the health status of retinal blood vessels. Using highly specialized cells in the blood, this study will try to discover a marker of DR.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Ability to cooperate with imaging procedures.

• Health status: established type 2 diabetes

• No history of panretinal photocoagulation (PRP)

• No history of treatment with intravitreal agents for past 12 months

Locations
United States
Indiana
Spring Mill Clinic
RECRUITING
Carmel
Eskenazi Eye Clinic
RECRUITING
Indianapolis
Glick Eye Institute
RECRUITING
Indianapolis
Contact Information
Primary
Ashay D Bhatwadekar, PhD, RPh
abhatwad@iupui.edu
3172785075
Backup
Amir R Hajrasouliha, MD
amhajras@iu.edu
3179441154
Time Frame
Start Date: 2022-01-01
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 192
Treatments
Healthy Control
Diabetes but no retinopathy
Mild non proliferative diabetic retinopathy
Moderate non proliferative diabetic retinopathy
Severe non proliferative diabetic retinopathy
Proliferative diabetic retinopathy
Related Therapeutic Areas
Sponsors
Leads: Indiana University

This content was sourced from clinicaltrials.gov